5 news items
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune's TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
ADAP
GLPG
30 May 24
-of concept trial and payments under the collaboration agreement, including milestone and royalty payments, the potential benefits of Adaptimmune's TCR
Galapagos creates new subscription right plans
GLPG
16 May 24
for the benefit of certain members of the personnel of the company and its subsidiaries. On 16 May 2024, the Board
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos' decentralized CAR-T manufacturing network in the U.S.
GLPG
15 May 24
manufacturing platform and our national cell therapy manufacturing footprint will ultimately benefit patients by providing convenient access to our
Galapagos reports first quarter 2024 financial results
GLPG
2 May 24
to the sales of Jyseleca® in Europe are to the benefit of Alfasigma.Collaboration revenues
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
GLPG
26 Mar 24
by such statements. These risks, uncertainties and other factors include, without limitation, the risk that we may not be able to realize the expected benefits
- Prev
- 1
- Next